Emerging orthobunyaviruses associated with CNS disease.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
10 2020
Historique:
received: 07 05 2020
accepted: 07 10 2020
revised: 09 11 2020
pubmed: 29 10 2020
medline: 9 2 2021
entrez: 28 10 2020
Statut: epublish

Résumé

The Orthobunyavirus genus comprises a wide range of arthropod-borne viruses which are prevalent worldwide and commonly associated with central nervous system (CNS) disease in humans and other vertebrates. Several orthobunyaviruses have recently emerged and increasingly more will likely do so in the future. Despite this large number, an overview of these viruses is currently lacking, making it challenging to determine importance from a One Health perspective. Causality is a key feature of determining importance, yet classical tools are unfit to evaluate the causality of orthobunyaviral CNS disease. Therefore, we aimed to provide an overview of orthobunyaviral CNS disease in vertebrates and objectify the causality strength of each virus. In total, we identified 27 orthobunyaviruses described in literature to be associated with CNS disease. Ten were associated with disease in multiple host species of which seven included humans. Seven viruses were associated with both congenital and postnatal CNS disease. CNS disease-associated orthobunyaviruses were spread across all known Orthobunyavirus serogroups by phylogenetic analyses. Taken together, these results indicate that orthobunyaviruses may have a common tendency to infect the CNS of vertebrates. Next, we developed six tailor-made causality indicators and evaluated the causality strength of each of the identified orthobunyaviruses. Nine viruses had a 'strong' causality score and were deemed causal. Eight had a 'moderate' and ten a 'weak' causality score. Notably, there was a lack of case-control studies, which was only available for one virus. We, therefore, stress the importance of proper case-control studies as a fundamental aspect of proving causality. This comprehensible overview can be used to identify orthobunyaviruses which may be considered causal, reveal research gaps for viruses with moderate to low causality scores, and provide a framework to evaluate the causality of orthobunyaviruses that may newly emerge in the future.

Identifiants

pubmed: 33112863
doi: 10.1371/journal.pntd.0008856
pii: PNTD-D-20-00797
pmc: PMC7652332
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0008856

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Infect Immun. 1977 Aug;17(2):338-43
pubmed: 892909
Emerg Infect Dis. 1995 Oct-Dec;1(4):147-51
pubmed: 8903187
Vet Res. 2015 Sep 23;46:99
pubmed: 26394618
Arch Virol. 2019 Jul;164(7):1949-1965
pubmed: 31065850
Clin Infect Dis. 2000 Oct;31(4):1113-4
pubmed: 11049801
Am J Trop Med Hyg. 1984 Nov;33(6):1218-27
pubmed: 6507732
Am J Trop Med Hyg. 1951 Nov;31(6):724-41
pubmed: 14894758
J Vet Diagn Invest. 1999 Mar;11(2):184-8
pubmed: 10098695
Emerg Infect Dis. 2018 Sep;24(9):1691-1695
pubmed: 30124416
Clin Infect Dis. 2019 Jan 1;68(1):139-142
pubmed: 29893821
Can Vet J. 1989 Aug;30(8):669-71
pubmed: 17423397
Trans R Soc Trop Med Hyg. 1974;68(2):114-23
pubmed: 4156616
J Med Virol. 2017 Jun;89(6):1108-1111
pubmed: 27787907
Am J Trop Med Hyg. 1960 Jan;9:62-9
pubmed: 14410617
Viruses. 2015 Nov 23;7(11):5987-6008
pubmed: 26610546
Am J Trop Med Hyg. 1967 Jan;16(1):63-73
pubmed: 4960485
Tijdschr Diergeneeskd. 2012 Feb;137(2):106-11
pubmed: 22393844
Am J Trop Med Hyg. 2012 Apr;86(4):732-5
pubmed: 22492162
J Vet Diagn Invest. 2002 Sep;14(5):363-70
pubmed: 12296386
Nat Rev Microbiol. 2014 Oct;12(10):673-85
pubmed: 25198140
Rev Soc Bras Med Trop. 2010 Sep-Oct;43(5):508-11
pubmed: 21085859
Arch Virol. 1975;47(1):71-83
pubmed: 1170831
Emerg Infect Dis. 2019 Feb;25(2):380-382
pubmed: 30666950
Am J Trop Med Hyg. 1991 Sep;45(3):371-6
pubmed: 1928573
N Engl J Med. 1997 Feb 20;336(8):547-9
pubmed: 9023091
J Clin Microbiol. 2013 Jun;51(6):1966-9
pubmed: 23515536
Neurology. 2010 Sep 7;75(10):924-32
pubmed: 20820004
J Child Neurol. 1999 Jan;14(1):1-14
pubmed: 10025535
PLoS One. 2013;8(3):e57747
pubmed: 23520481
BMC Vet Res. 2008 Jun 13;4:20
pubmed: 18554406
Bull Soc Med Afr Noire Lang Fr. 1969;14(1):88-92
pubmed: 5399299
Nature. 2004 Jul 8;430(6996):242-9
pubmed: 15241422
J Wildl Dis. 1975 Jul;11(3):348-56
pubmed: 1152173
Emerg Infect Dis. 2017 Jun;23(6):993-996
pubmed: 28518043
J Vet Med Sci. 1998 Oct;60(10):1139-40
pubmed: 9819769
Am J Epidemiol. 1965 Mar;81:245-53
pubmed: 14261030
Vet Pathol. 1998 Sep;35(5):409-11
pubmed: 9754547
N Engl J Med. 2019 Jun 13;380(24):2327-2340
pubmed: 31189036
Can Commun Dis Rep. 2007 Oct 1;33(11):23-6
pubmed: 18161204
Emerg Infect Dis. 2012 Mar;18(3):469-72
pubmed: 22376991
PLoS One. 2012;7(7):e40380
pubmed: 22792298
Epidemiol Infect. 2013 Jan;141(1):1-8
pubmed: 23046921
Infect Genet Evol. 2014 Mar;22:164-73
pubmed: 24480054
Transbound Emerg Dis. 2019 May;66(3):1126-1131
pubmed: 30864252
Am J Vet Res. 1990 Oct;51(10):1645-8
pubmed: 2122779
J Vet Diagn Invest. 1994 Apr;6(2):250-4
pubmed: 8068759
Emerg Infect Dis. 2015 Dec;21(12):2267-8
pubmed: 26583957
Epilepsia Open. 2018 Apr 17;3(2):286-289
pubmed: 29881809
Clin Microbiol Infect. 2016 Jul;22(7):583-4
pubmed: 27064135
Am J Epidemiol. 1973 Mar;97(3):199-207
pubmed: 4692993
Virus Res. 1997 May;48(2):143-8
pubmed: 9175252
Am J Trop Med Hyg. 1997 Feb;56(2):171-6
pubmed: 9080876
Pediatrics. 1997 Feb;99(2):261-7
pubmed: 9024460
Open Forum Infect Dis. 2017 Jul 22;4(3):ofx150
pubmed: 28948178
Neurology. 1969 Apr;19(4):394-404
pubmed: 4975837
Emerg Infect Dis. 2012 Feb;18(2):318-21
pubmed: 22305525
Emerg Microbes Infect. 2020 Dec;9(1):903-912
pubmed: 32302268
Vopr Virusol. 1998 Jan-Feb;43(1):14-7
pubmed: 9559529
Vet Pathol. 2012 Jul;49(4):588-91
pubmed: 22610033
Vet J. 2015 Oct;206(1):111-4
pubmed: 26183295
Sci Rep. 2013 Nov 28;3:3361
pubmed: 24285292
Viruses. 2014 Oct 10;6(10):3827-36
pubmed: 25310583
Emerg Infect Dis. 2016 May;22(5):810-7
pubmed: 27088268
Vopr Virusol. 1995 Mar-Apr;40(2):72-4
pubmed: 7762235
Vopr Virusol. 1995 Jan-Feb;40(1):21-5
pubmed: 7740783
Ann Neurol. 2017 Jul;82(1):105-114
pubmed: 28628941
Aust Vet J. 1975 Dec;51(12):584-5
pubmed: 1222008
Am J Trop Med Hyg. 2015 Aug;93(2):384-9
pubmed: 26033022
Clin Infect Dis. 1999 Jun;28(6):1294-7
pubmed: 10451169
J Am Vet Med Assoc. 1985 Feb 15;186(4):389
pubmed: 3972700
Calif Med. 1952 Nov;77(5):303-9
pubmed: 13009479
J Am Vet Med Assoc. 1983 Sep 1;183(5):555-8
pubmed: 6413468
Aust Vet J. 1978 Mar;54(3):151-2
pubmed: 687271
Vet Pathol. 1989 Jan;26(1):33-9
pubmed: 2492399
Virus Res. 2011 Jan;155(1):35-41
pubmed: 20727376
Emerg Infect Dis. 2013 Jan;19(1):154-5
pubmed: 23260872
Emerg Infect Dis. 2006 May;12(5):854-6
pubmed: 16704854
Yale J Biol Med. 1976 May;49(2):175-95
pubmed: 782050
Genes (Basel). 2019 Apr 30;10(5):
pubmed: 31052348
Vet Res. 2004 Sep-Oct;35(5):531-8
pubmed: 15369656
Emerg Infect Dis. 2001 May-Jun;7(3):451-2
pubmed: 11384526
Zoonoses Public Health. 2019 Nov;66(7):739-758
pubmed: 31254324
Am J Trop Med Hyg. 1988 Oct;39(4):409-16
pubmed: 3189702
J Gen Virol. 2003 Oct;84(Pt 10):2685-2689
pubmed: 13679602

Auteurs

Arthur Wouter Dante Edridge (AWD)

Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam institute for Infection & Immunity, Amsterdam UMC, University of Amsterdam, the Netherlands.
Global Child Health Group, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, the Netherlands.

Lia van der Hoek (L)

Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam institute for Infection & Immunity, Amsterdam UMC, University of Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH